Pages that link to "Q53556858"
Jump to navigation
Jump to search
The following pages link to Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations. (Q53556858):
Displaying 26 items.
- Retinoic acid and arsenic for treating acute promyelocytic leukemia (Q24809165) (← links)
- Retinoic acid mimics transforming growth factor beta in the regulation of human immunodeficiency virus expression in monocytic cells (Q28316144) (← links)
- Silibinin can induce differentiation as well as enhance vitamin D3-induced differentiation of human AML cells ex vivo and regulates the levels of differentiation-related transcription factors (Q33927891) (← links)
- Synthetic retinoids in dermatology (Q34299257) (← links)
- Top five medical innovations in China mainland since Xinhai revolution [1911]: results of AME survey-002. (Q35589141) (← links)
- Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma (Q35832541) (← links)
- Mature T-lineage leukemia with growth factor-induced multilineage differentiation (Q36356152) (← links)
- Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies (Q36750049) (← links)
- Host and microbial factors in regulation of T cells in the intestine (Q36914741) (← links)
- Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications (Q37195857) (← links)
- Retinoic acid: A key player in immunity (Q37783965) (← links)
- Progress in the treatment of acute promyelocytic leukemia: optimization and obstruction (Q38221006) (← links)
- Acute myelogenous leukaemia in children (Q38605919) (← links)
- Drug repurposing in oncology--patient and health systems opportunities. (Q38611707) (← links)
- Antiproliferative effect of 13-cis-retinoic acid is associated with granulocyte differentiation and decrease in cyclin B1 and Bcl-2 protein levels in G0/G1 arrested HL-60 cells (Q39750511) (← links)
- Differentiation-inducing potency of the seco-steroid JK-1624F2-2 can be increased by combination with an antioxidant and a p38MAPK inhibitor which upregulates the JNK pathway (Q40116924) (← links)
- Sphinganine potentiation of cellular differentiation induced by various anti-leukemia drugs in human leukemia cell line HL-60. (Q41432834) (← links)
- Nongenomic vitamin D3 analogs activating ERK2 in HL-60 cells show that retinoic acid-induced differentiation and cell cycle arrest require early concurrent MAPK and RAR and RXR activation (Q43595106) (← links)
- Resolution of recurrent malignant ganglioglioma after treatment with cis-retinoic acid (Q48908980) (← links)
- Retinoic acid selectively activates the ERK2 but not JNK/SAPK or p38 MAP kinases when inducing myeloid differentiation. (Q53779134) (← links)
- In vitro evidence for dose-dependent cytotoxicity as the predominant effect of low dose Ara-C on human leukemic and normal marrow cells (Q69936119) (← links)
- Interaction of liposome-associated all-trans-retinoic acid with squamous carcinoma cells (Q72711267) (← links)
- Repeated complete remission in a patient with acute promyelocytic leukemia after treatment with 13-cis-retinoic acid first and with all-trans-retinoic acid in relapse (Q72768072) (← links)
- PML Bodies in Mitosis (Q92641896) (← links)
- Targeting the differentiation of gastric cancer cells (KATO‑III) downregulates epithelial‑mesenchymal and cancer stem cell markers (Q92981941) (← links)
- Isotretinoin is active in the initial management of acute pro-myelocytic leukemia (Q98577048) (← links)